Smart Asymmetric Hydrogel with Integrated Multi‐Functions of NIR‐Triggered Tunable Adhesion, Self‐Deformation, and Bacterial Eradication

2021 ◽  
pp. 2100784
Author(s):  
Lan Feng ◽  
Wenbin Shi ◽  
Qin Chen ◽  
Huitong Cheng ◽  
Jianxu Bao ◽  
...  
Tetrahedron ◽  
2016 ◽  
Vol 72 (25) ◽  
pp. 3559-3566 ◽  
Author(s):  
Kevin P.C. Minbiole ◽  
Megan C. Jennings ◽  
Laura E. Ator ◽  
Jacob W. Black ◽  
Melissa C. Grenier ◽  
...  

2021 ◽  
pp. 2107530
Author(s):  
Ling Li ◽  
Lijian Cao ◽  
Xi Xiang ◽  
Xizheng Wu ◽  
Lang Ma ◽  
...  

2013 ◽  
Vol 85 (4) ◽  
pp. 190 ◽  
Author(s):  
Konstantinos Stamatiou ◽  
Nikolaos Pierris

Introduction: Chronic prostatitis displays a variety of symptoms (mainly local pain exhibiting variability in origin and intensity). The purpose of this article is to briefly present the preliminary results of our study examining the role of phytotherapeutic agents in the treatment of chronic prostatitis patients. Materials and methods: The study included in total fifty-six consecutive patients who visited the outpatient department. Subjects were randomized into two groups. Subjects in the first group (28 patients) received prulifloxacin 600 mg for 15 days, while subjects in the second group (28 patients) received prulifloxacin 600 mg for 15 days and Serenoa repens extract for 8 weeks. The response was tested using laboratory and clinical criteria. Results: We found statistically significant differences between the two groups regarding pain regression and no statistically significant regarding bacterial eradication. Moreover however while sexual dysfunction improvement was equally achieved in both groups, improvement of urinary symptoms was more evident in the 2nd group especially after the completion of the antibiotic treatment. Conclusions: Serenoa repens extract for 8 weeks seems to improve prostatitis related pain. Further randomized, placebo-controlled studies are needed to substantiate safer conclusions.


2009 ◽  
Vol 296 (3) ◽  
pp. R587-R594 ◽  
Author(s):  
Premysl Bercik ◽  
Elena F. Verdú ◽  
Jane A. Foster ◽  
Jun Lu ◽  
Angela Scharringa ◽  
...  

Bacterial infection can trigger the development of functional GI disease. Here, we investigate the role of the gut-brain axis in gastric dysfunction during and after chronic H. pylori infection. Control and chronically H. pylori-infected Balb/c mice were studied before and 2 mo after bacterial eradication. Gastric motility and emptying were investigated using videofluoroscopy image analysis. Gastric mechanical viscerosensitivity was assessed by cardioautonomic responses to distension. Feeding patterns were recorded by a computer-assisted system. Plasma leptin, ghrelin, and CCK levels were measured using ELISA. IL-1β, TNF-α, proopiomelanocortin (POMC), and neuropeptide Y mRNAs were assessed by in situ hybridizations on frozen brain sections. Gastric inflammation was assessed by histology and immunohistochemistry. As shown previously, H. pylori-infected mice ate more frequently than controls but consumed less food per bout, maintaining normal body weight. Abnormal feeding behavior was accompanied by elevated plasma ghrelin and postprandial CCK, higher TNF-α (median eminence), and lower POMC (arcuate nucleus) mRNA. Infected mice displayed delayed gastric emptying and visceral hypersensitivity. Eradication therapy normalized gastric emptying and improved gastric sensitivity but had no effect on eating behavior. This was accompanied by persistently increased TNF-α in the brain and gastric CD3+ T-cell counts. In conclusion, chronic H. pylori infection in mice alters gastric emptying and mechanosensitivity, which improve after bacterial eradication. A feeding pattern reminiscent of early satiety persists after H. pylori eradication and is accompanied by increased TNF-α in the brain. The results support a role for altered gut-brain pathways in the maintenance of postinfective gut dysfunction.


2020 ◽  
Vol 12 (12) ◽  
pp. 13698-13708 ◽  
Author(s):  
Ye Yang ◽  
Xizheng Wu ◽  
Chao He ◽  
Jianbo Huang ◽  
Shiqi Yin ◽  
...  

Molecules ◽  
2020 ◽  
Vol 25 (2) ◽  
pp. 294 ◽  
Author(s):  
Eveliina Taavitsainen ◽  
Maarit Kortesoja ◽  
Tanja Bruun ◽  
Niklas G. Johansson ◽  
Leena Hanski

Antibiotic-tolerant persister bacteria involve frequent treatment failures, relapsing infections and the need for extended antibiotic treatment. The virulence of an intracellular human pathogen C. pneumoniae is tightly linked to its propensity for persistence and means for its chemosensitization are urgently needed. In the current work, persistence of C. pneumoniae clinical isolate CV6 was studied in THP-1 macrophages using quantitative PCR and quantitative culture. A dibenzocyclooctadiene lignan schisandrin reverted C. pneumoniae persistence and promoted productive infection. The concomitant administration of schisandrin and azithromycin resulted in significantly improved bacterial eradication compared to sole azithromycin treatment. In addition, the closely related lignan schisandrin C was superior to azithromycin in eradicating the C. pneumoniae infection from the macrophages. The observed chemosensitization of C. pneumoniae was associated with the suppression of cellular glutathione pools by the lignans, implying to a previously unknown aspect of chlamydia–host interactions. These data indicate that schisandrin lignans induce a phenotypic switch in C. pneumoniae, promoting the productive and antibiotic-susceptible phenotype instead of persistence. By this means, these medicinal plant -derived compounds show potential as adjuvant therapies for intracellular bacteria resuscitation.


Nano Letters ◽  
2019 ◽  
Vol 19 (9) ◽  
pp. 5885-5896 ◽  
Author(s):  
Xin Fan ◽  
Fan Yang ◽  
Jianbo Huang ◽  
Ye Yang ◽  
Chuanxiong Nie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document